# OnCo record nct05801237 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct05801237/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct05801237", "NCT05801237" ;
  schema:name "PE0116 and PE0105 Injection in Treatment of Patients With Advanced Solid Tumor"@en ;
  schema:description "A phase 1/2 trial of PE0116&PE0105 in advanced solid tumours, run by Shanghai HyaMab Biotech Co.,Ltd., now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct05801237/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05801237> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1/2" ;
  schema:startDate "2023-09-21" ;
  onco:cancers <https://onco.cc/cancers/metastatic-cancer/> .